New trial - half the patients with HF have HFpEF and half them have PAH - this new trial of C-Pulse (funding or grants permitted) should have less trouble finding patients as there are only a few trials involving these preserved ejection fraction patients according to my previous post on the 04/01
"Approximately half of patients with systolic heart failure or preserved ejection fraction heart failure (HFpEF) have PAH with similar 5-year outcomes."
